INTERNATIONAL PATENT: ULTRAGENYX PHARMACEUTICAL INC. FILES APPLICATION FOR "COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH UBE3A OVEREXPRESSION"

GENEVA, June 25 -- ULTRAGENYX PHARMACEUTICAL INC. (60 Leveroni CourtNovato, California 94949) filed a patent application (PCT/US2024/059822) for "COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH UBE3A OVEREXPRESSION" on Dec 12, 2024. With publication no. WO/2025/128853, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SWISTOWSKI, Andrzej (c/o Ultragenyx Pharmaceutical Inc.60 Leveroni CourtNovato, California 94949), DINDOT, Scott Victor (c/o Ultragenyx Pharmaceutical Inc.60 Leveroni CourtNovato, California 9...